@article{ATM17553,
author = {Manyoo Agarwal and Sahil Agrawal and Lohit Garg and Guy L. Reed and Rami N. Khouzam and Uzoma N. Ibebuogu},
title = {Impact of smoking in patients undergoing transcatheter aortic valve replacement},
journal = {Annals of Translational Medicine},
volume = {6},
number = {1},
year = {2017},
keywords = {},
abstract = {Background: The paradox that smokers have better clinical outcomes in cardiovascular diseases remains controversial. No literature exists studying impact of smoking on outcomes following transcatheter aortic valve replacement (TAVR).
Methods: We performed an electronic search of the 2011–2012 National Inpatient Sample (NIS) database to identify all TAVR hospitalizations. Outcomes were measured comparing smokers to non-smokers.
Results: A total of 8,345 TAVR hospitalizations were identified with 24% being smokers. Compared to non-smokers, smokers were younger (80.4±8.8 vs. 81.4±9.2 years, P},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/17553}
}